2026-01-15
New study shows patients taking GLP-1 drug who commit to digital coaching achieve 30% better results vs medication alone
New study from Voy shows that patients taking a GLP-1 drug who engaged with coaching sessions and app-based support over the course of 12 months achieved a 30% higher relative body weight loss compared to those using medication alone. (London, January 15, 2026) Voy, the digital health provider, has announced the publication of a new study in the Journal of Medical Internet Research analyzing the efficacy of a GLP-1 drug for achieving weight loss results in patients who engage regularly with a supporting coaching program compared to patients who rely on the medication alone. The large-scale study examined the progress of over 126,000 UK-based Voy patientsRead More →